The Renaissance of Renal Care: A Visionary Roadmap for the Chronic Kidney Disease (CKD) Drugs Market (2024–2032) Executive Summary: The Strategic Pivot from Management to Modification For decades, the Chronic Kidney Disease (CKD) drugs market was defined by a reactive stance—managing blood pressure and treating complications like anemia or mineral bone disorders. However,...